Exosome‐delivered miR‐221/222 exacerbates tumor liver metastasis by targeting SPINT1 in colorectal cancer

Fei Tian,Peiyun Wang,Dan Lin,Jiajia Dai,Qibing Liu,Yu Guan,Yang Zhan,Yichen Yang,Wenpeng Wang,Jiefu Wang,Jia Liu,Lei Zheng,Yan Zhuang,Jun Hu,Junfeng Wang,Dalu Kong,Kegan Zhu
DOI: https://doi.org/10.1111/cas.15028
IF: 5.7
2021-07-07
Cancer Science
Abstract:<p>MicroRNAs (miRNAs) are involved in the progression of many cancers through largely unelucidated mechanisms. The results of our present study identified a gene cluster, miR-221/222, that is constitutively upregulated in serum exosome samples of patients with colorectal carcinoma (CRC) with liver metastasis (LM), and this upregulation predicts a poor overall survival rate. Using an in vitro cell coculture model, we demonstrated that CRC exosomes harboring miR-221/222 activate liver hepatocyte growth factor (HGF) by suppressing SPINT1 expression. Importantly, miR-221/222 plays a key role in forming a favorable premetastatic niche (PMN) that leads to the aggressive nature of CRC, which was further shown through in vivo studies. Overall, our results show that exosomal miR-221/222 promotes CRC progression and may serve as a novel prognostic marker and therapeutic target for CRC with LM.</p>
oncology
What problem does this paper attempt to address?